Frieling, Thomas
Martin, Eric
Fischer, Steffen
Pohl, Daniel
Ude, Christian
Funding for this research was provided by:
Sanofi-Aventis Deutschland
Article History
Accepted: 8 January 2023
First Online: 31 January 2023
Declarations
:
: This manuscript and the journal's open access fee were funded by Sanofi-Aventis Consumer Healthcare, Germany.
: TF has acted as a consultant and/or speaker for Dr. Willmar Schwabe GmbH & Ko. KG, Sanofi-Aventis Deutschland GmbH, Takeda Pharma Vertriebs GmbH & Ko. KG, Falk Foundation e. V., Medizinisches Forum, Forum Medizinische Fortbildung, Promedia Medizintechnik, MEDICE Arzneimittel Pütter GmbH & Ko KG, ABOCA Group, S.p.A and Reckitt Benckiser Deutschland GmbH. EM has acted as a consultant and/or speaker for AstraZeneca, Berlin Chemie, GSK, Infectopharm Arzneimittel and Sanofi-Aventis. SF has acted as a consultant and/or speaker for St. Elisabethen Universität, ACEKI e.V., Infectopharm Arzneimittel und Consilium, Pädia, Köhler Pharma and Sanofi Deutschland. DP has acted as a consultant and/or speaker and/or has received research support from Alfa Sigma, Dr. Willmar Schwabe, Medtronic, Permamed and Sanofi-Aventis. CU has acted as a consultant/speaker for Bionorica, Infectopharm Arzneimittel, Consilium, Dr. Willmar Schwabe and Sanofi-Aventis.
: Not applicable (not a clinical trial).
: Not applicable (not a clinical trial).
: Not applicable (not a clinical trial).
: This article was developed based on input from expert advisors (CU, DP, EM and TF, who attended a virtual roundtable meeting in May 2020). These authors received an honorarium to participate in the meeting. The paediatric input was provided by SF, who received an honorarium for his consultation. All authors made substantial contributions to the preparation of this article, critical evaluation and revision of all drafts and gave final approval for submission.